OrbiMed's Biopharma Portfolio

ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.

ACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies.

Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.

Shattuck Labs is a biotechnology company that provides novel class biologic medicines for the treatment of cancer and autoimmune disease.

Whitehawk Therapeutics, a clinical-stage oncology therapeutics firm, applies cutting-edge technologies to well-established tumor biology.

Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.

Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.

ImageneBio is dedicated to developing therapeutics for patients with immunological, autoimmune and inflammatory diseases

Lomond Therapeutics creates pharmacological platforms that target escape mutations.

Pinnacle Medicines is a peptide drug discovery company that provides peptide modality for medical needs.

Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.

Harvest Integrated Research Organization (HiRO) is a globally oriented, innovative clinical research organization (CRO).

Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing radiopharmaceuticals.

Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.

ENYO Pharma is a biopharmaceutical company based in Lyon, France.

Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.

Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies.

Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases.

89bio is a biopharmaceutical company that develops clinical-stage therapies for liver and cardiometabolic diseases.

SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.

Mendra uses AI to accelerate clinical development and commercialization of breakthrough medicines for diseases with high unmet need.

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.

BlossomHill Therapeutics is a biopharmaceutical company focusing on oncology and autoimmune disorders.

Verastem is a biopharmaceutical company developing new medicines to improve the lives of patients with RAS/MAPK pathway-driven cancers.

Adicet Bio is a biotechnology company discovering and developing first-in-class allogeneic gamma delta CAR t cell therapies for cancer

Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.

QL Biopharma focuses on developing innovative drugs and premium me-too drugs targeting metabolic diseases.

NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.

Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.

Minghui Pharmaceutical is a biopharmaceutical business that specializes in immunology and oncology medicines for unmet needs.

Pathalys is a clinical biopharmaceutical company that develops therapeutics that improve late-stage chronic kidney disease.

Gemini Therapeutics focuses on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases.

InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs.

PMV Pharmaceuticals is a developer of p53-targeted small molecule drugs for the treatment of cancer.

Cleave Therapeutics is focused on protein homeostasis and stress pathways in cancer and neurodegeneration.

resTORbio is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics.